Purple Biotech PPBT
NASDAQ PPBT
$1.52 +0.00 (+0.00%)
At close: Sep 30, 2026 · 4:00 PM EDT

Purple Biotech (PPBT) Other Operating Expenses (2024 - 2025)

Updated

Purple Biotech (PPBT) reported Other Operating Expenses of $20.48 million for Q4 2025.

Analysis

Purple Biotech (PPBT) Other Operating Expenses (2024 - 2025) Analysis & Trends

For FY2025, Purple Biotech posted Other Operating Expenses of $20.22 million.

  • By year, Other Operating Expenses came in at -$46,000 in FY2024, -$393,000 in FY2023 and -$321,000 in FY2022.
  • The Q4 2025 figure ranks as the lowest quarterly Other Operating Expenses since Q2 2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn
10 Purple Biotech 249,214.64 191,214.64 -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 20.48 Mn
Jun 30, 2024 202,000.00
API Access

Purple Biotech Other Operating Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-operating-expenses&ticker=PPBT&period=max&api_key=YOUR_API_KEY